OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds that modulate the microbiome to tackle metabolic syndrome, low-grade systemic inflammation, obesity and diabetes, cardiovascular disease and high cholesterol, announces that SlimBiome® has received approval for use as a licensed product for weight management by Health Canad…
© 2024 📈 🐝 Small Company Champion
Substack is the home for great culture